Simultaneous cholecystectomy is associated with increased low-grade postoperative morbidity after minor liver resection for metastatic disease: a retrospective single-center cohort study

Abstract Purpose Simultaneous cholecystectomy (sCHE) is frequently performed during liver resection for metastatic disease for technical or prophylactic reasons, but its impact on postoperative morbidity remains unclear. Methods This retrospective single-center study included 472 patients undergoing liver resection for metastatic disease between 2007 and 2023. Patients were stratified by sCHE status. Postoperative complications were assessed using the Clavien-Dindo classification, with subgroup analyses according to minor or major liver resection. Results Baseline characteristics were comparable between groups, although patients undergoing sCHE had a higher metastatic burden and more frequently received preoperative liver-directed therapies. Postoperative complications occurred more often after sCHE in the overall cohort (55% vs. 45%, p = 0.039), particularly after minor liver resection (56% vs. 39%, p = 0.003). This difference was mainly driven by low-grade Clavien-Dindo complications (47% vs. 26%, p < 0.001), whereas major complications remained comparable ( p = 0.410). No significant difference in postoperative morbidity was observed after major liver resection (57% vs. 70%, p = 0.292). In multivariable analysis, sCHE was not independently associated with postoperative morbidity, while operative duration remained a significant predictor of complications. Conclusion The present findings do not provide evidence supporting routine prophylactic cholecystectomy during liver resection for metastatic disease in the absence of a clear clinical or surgical indication. Increased morbidity observed after minor liver resection was predominantly driven by low-grade complications. The association was not confirmed after multivariable adjustment, potentially reflecting procedural complexity.

Authors

Institutions

Publication Details

Journal
Langenbeck s Archives of Surgery
Published
2026-11-16
DOI
https://doi.org/10.1007/s00423-026-04375-x
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Simultaneous cholecystectomy is associated with increased low-grade postoperative morbidity after minor liver resection for metastatic disease: a retrospective single-center cohort study

Helmut Friess, Norbert Hueser, U. Nitsche, Nick Seyfried et al.
1 links
Langenbeck s Archives of Surgery
Hepatocellular Carcinoma Treatment and Prognosis
article

Simultaneous cholecystectomy is associated with increased low-grade postoperative morbidity after minor liver resection for metastatic disease: a retrospective single-center cohort study

Helmut Friess, Norbert Hueser, U. Nitsche, Nick Seyfried, Christian Stoess, Celine Appel
article en

Abstract

Abstract Purpose Simultaneous cholecystectomy (sCHE) is frequently performed during liver resection for metastatic disease for technical or prophylactic reasons, but its impact on postoperative morbidity remains unclear. Methods This retrospective single-center study included 472 patients undergoing liver resection for metastatic disease between 2007 and 2023. Patients were stratified by sCHE status. Postoperative complications were assessed using the Clavien-Dindo classification, with subgroup analyses according to minor or major liver resection. Results Baseline characteristics were comparable between groups, although patients undergoing sCHE had a higher metastatic burden and more frequently received preoperative liver-directed therapies. Postoperative complications occurred more often after sCHE in the overall cohort (55% vs. 45%, p = 0.039), particularly after minor liver resection (56% vs. 39%, p = 0.003). This difference was mainly driven by low-grade Clavien-Dindo complications (47% vs. 26%, p < 0.001), whereas major complications remained comparable ( p = 0.410). No significant difference in postoperative morbidity was observed after major liver resection (57% vs. 70%, p = 0.292). In multivariable analysis, sCHE was not independently associated with postoperative morbidity, while operative duration remained a significant predictor of complications. Conclusion The present findings do not provide evidence supporting routine prophylactic cholecystectomy during liver resection for metastatic disease in the absence of a clear clinical or surgical indication. Increased morbidity observed after minor liver resection was predominantly driven by low-grade complications. The association was not confirmed after multivariable adjustment, potentially reflecting procedural complexity.

Langenbeck s Archives of SurgeryVol. 412(1)
TUM Klinikum (DE), Technical University of Munich (DE)
Technische Universität München
Good health and well-being
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon